Use of Sufoof-e-zaj and Marham e Mazu in Treatment of Piles

Therapeutic Evaluation of Safoof Zaj and Marham-e-Mazu in Bawaseer (Haemorrhoids): An Open Observational Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/024135

Enrollment

Registered

2020-03-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K640- First degree hemorrhoids Health Condition 2: K648- Other hemorrhoids Health Condition 3: K641- Second degree hemorrhoids

Interventions

Intervention1: Safoof Zaj and Marham Mazu: Powder form of Safoof Zaj (Alum) for sitz bath in QS Ointment of Mazu (Quercus infectoria) for local application in QS Duration of the protocol therapy: 14 d

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with symptomatic uncomplicated haemorrhoids (Grade I, II Internal haemorrhoids) 2. External haemorrhoids). 3. Patients from 18 - 60 years of age.

Exclusion criteria

Exclusion criteria: 1. Patients with severe anaemia. 2. Pregnant and lactating mothers. 3. Bleeding dyscrasias. 4. Systematic illness (Including Hypertension and Diabetes mellitus)

Design outcomes

Primary

Measure	Time frame
1)Pain intensity 2)Haemorrhoidal itching 3)Defecate discomfort 4.Per rectal bleeding Timepoint: before and after	—

Secondary

Measure	Time frame
Quality of lifeTimepoint: Before and After the Trial;Reduction in Size of PileTimepoint: Before and After the Trial	—

Countries

India

Contacts

Public ContactDr MOHD KHALID

Luqman Unani Medical College, Hospital and Research Centre

drqudrathullah@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026